tiprankstipranks
Mira Pharmaceuticals announces new in vitro preclinical data on SKNY-1
PremiumThe FlyMira Pharmaceuticals announces new in vitro preclinical data on SKNY-1
14d ago
MIRA Pharmaceuticals Reveals Promising SKNY-1 Preclinical Data
Premium
Company Announcements
MIRA Pharmaceuticals Reveals Promising SKNY-1 Preclinical Data
14d ago
Mira Pharmaceuticals announces Ketamir-2 manuscript accepted for publication
Premium
The Fly
Mira Pharmaceuticals announces Ketamir-2 manuscript accepted for publication
21d ago
MIRA Pharmaceuticals Appoints New Chief Financial Officer
PremiumCompany AnnouncementsMIRA Pharmaceuticals Appoints New Chief Financial Officer
2M ago
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
Premium
The Fly
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
2M ago
Mira Pharmaceuticals announces board approval of SKNY acquisition
Premium
The Fly
Mira Pharmaceuticals announces board approval of SKNY acquisition
2M ago
Mira Pharmaceuticals reports in vitro drug release data for topical Ketamir-2
PremiumThe FlyMira Pharmaceuticals reports in vitro drug release data for topical Ketamir-2
3M ago
Psychedelic: MindMed announces dosing in Phase 3 Emerge study
Premium
The Fly
Psychedelic: MindMed announces dosing in Phase 3 Emerge study
3M ago
Mira Pharmaceuticals announces results for Ketamir-2 in diabetic neuropathy
Premium
The Fly
Mira Pharmaceuticals announces results for Ketamir-2 in diabetic neuropathy
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100